Medicare Enrolled

Dr. Yevgeniy Khariton, M.D

Internal Medicine · Temple, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Research-focused
2401 S 31ST ST, Temple, TX 76508
2547242111
In practice since 2013 (12 years)
NPI: 1154760320 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khariton from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khariton? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khariton

Dr. Yevgeniy Khariton is an internal medicine specialist in Temple, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Khariton performed 136 Medicare services across 67 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khariton received a total of $18,587 from 16 pharmaceutical and/or device companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khariton is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ 136 Medicare services $18,587 industry payments

Medicare Practice Summary

Medicare Utilization ↗
136
Medicare services
Bottom 14% in TX for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
67
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~11 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity 102 $61 $139
Office visit, established patient (30-39 min) 18 $59 $209
Initial hospital admission, moderate complexity 16 $100 $267
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,587
Total received (2018-2024)
Avg $2,655/year across 7 years
Top 5% in TX for internal medicine
16
Companies
113
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$11,216 (60.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,372 (39.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$599
2023
$874
2022
$3,694
2021
$11,216
2020
$294
2019
$1,357
2018
$554

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$16,196
Medtronic, Inc.
$640
ABIOMED
$318
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$263
AstraZeneca Pharmaceuticals LP
$226
Medtronic Vascular, Inc.
$209
Nuwellis, Inc.
$185
E.R. Squibb & Sons, L.L.C.
$159
ENDOTRONIX, INC.
$126
SCPHARMACEUTICALS INC.
$125
Boston Scientific Corporation
$33
Alnylam Pharmaceuticals Inc.
$28
Novartis Pharmaceuticals Corporation
$25
PFIZER INC.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Amgen Inc.
$13
Top 3 companies account for 92.3% of total payments
Associated products mentioned in payments ›
Adapta · Aquadex Smartflow Console · BRILINTA · CAMZYOS · CARDIOMEMS · CORDELLA PULOMONARY ARTERY PRESSURE SENSOR · CardioMEMS HF System · ELIQUIS · ENTRESTO · Ellipse ICD · Ensite Cardiac Mapping System · FARXIGA · FUROSCIX · Fortify Assura · HeartMate 3 Left Ventricular Dev · HeartMate Touch · Impella · LifeVest · MITRACLIP · ONPATTRO · Quadra Assura CRT Defibrillator · Repatha · Resolute · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VYNDAQEL · WAINUA · WATCHMAN Access System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 5% for internal medicine in TX.

Equivalent to $13,667 per 100 Medicare services performed
Looking for an internal medicine specialist in Temple?
Compare internal medicine physicians in the Temple area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Khariton is a mixed practice specialist, with moderate Medicare volume, with research-focused industry engagement in the top 5% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Khariton experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Khariton performed 102 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khariton receive payments from pharmaceutical companies?
Yes. Dr. Khariton received a total of $18,587 from 16 companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khariton's costs compare to other internal medicine physicians in Temple?
Dr. Khariton's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khariton) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →